My site

Credit Risk Measurement and Management: Disruption and Evolution, edited by Amnon Levy and Jing Zhang, traces the evolution of credit risk management, with contributions from economist Nouriel Roubini, KMV and DCI co-founder Stephen Kealhofer, Prudential CRO Nick Silitch, and other leading thinkers.

SAN FRANCISCO-Tuesday 3 December 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- Moody’s Analytics, a leading provider of financial intelligence, today announced the release of Credit Risk Measurement and Management: Disruption and Evolution, edited by Moody’s Analytics experts Dr. Amnon Levy, Head of Portfolio and Balance Sheet Research, and Dr. Jing Zhang, Global Head of Research and Modeling. Other Moody’s Analytics experts contributing to the book include Dr. Douglas Dwyer, Dr. Tony Hughes, Dr. Ashit Talukder, Elaine Wong, and Dr. Pierre Xu.

Published by Risk Books, this book includes 15 chapters representing a broad selection of perspectives fr ... Read more »

Exclusivity agreement demonstrates joint commitment to bringing pioneering digital heart health technology to insurance community.

STAMFORD, Conn.-Tuesday 3 December 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- Decades of evidence have proven cardiorespiratory fitness to be a leading predictor of longevity and future health. Yet it is one that has been largely overlooked within insurance customer health profiles. With the signing of the exclusive agreement between leading global reinsurer, Gen Re, and health technology software company, PAI Health, this is set to change.

PAI Health is known for its innovation in biometric sensing and algorithm development with unique data insights rooted in cardiorespiratory fitness. The company’s digital services are based on published research that has demonstrated the effectiveness of the heart rate-based metric called Personal Activity Intelligence (PAI) in recommending personalized activity levels for optimal mortality ri ... Read more »

LACHEN, Switzerland-Tuesday 3 December 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- Octapharma has announced that the final results of the NuProtect study will be presented by Dr Ri Liesner (Great Ormond Street Hospital for Children, London, UK) as an oral presentation at the 61st Annual Meeting of the American Society of Hematology (ASH) 2019 in Orlando, Florida.

Dr Liesner commented that “I am excited to be representing the NuProtect study group to share these data. The data should help to inform clinical decision-making and provide valuable evidence to reassure clinicians and patients that Nuwiq® is an effective treatment option for PUPs”.

The NuProtect study is the largest prospective study of a single FVIII concentrate in true PUPs with haemophilia A. The study assessed the immunogenicity, efficacy and safety of the human cell line-derived recombinant FVIII Nuwiq® (simoctocog alfa) in 108 PUPs. Final results on the immunogenicity, efficacy a ... Read more »